SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Nov 8, 2012
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: Nov. 8, 2012 · CIK: 0001433607 · Accession: 0001144204-12-060531
AI Filing Summary & Sentiment
File numbers found in text: 333-184066
Show Raw Text
CORRESP
1
filename1.htm
November 8, 2012
U.S. Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Re: InspireMD, Inc.
Registration Statement on Form S-1
Filed September 24, 2012
File No. 333-184066
VIA FACSIMILE
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of
the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Cowen and Company, LLC, as representative
of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that
it will become effective at 11:00 a.m., Washington D.C. time, on November 13, 2012, or as soon thereafter as practicable.
The following is supplemental information supplied under Rule
418(a)(7) and Rule 460 under the Securities Act of 1933:
(i) Date of preliminary prospectuses: October 29, 2012
(ii) Dates of distribution: The preliminary prospectus dated
October 29, 2012 was distributed from October 30, 2012 to November 8, 2012
(iii) Number of prospective underwriters and dealers to whom
preliminary prospectuses were furnished: 2
(iv) Number of prospectuses so distributed: 100
The undersigned confirms that is has complied with and will
continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or
will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced
issue.
COWEN AND COMPANY, LLC
By:
/s/ Kevin Raidy
Name:
Kevin Raidy
Title:
Managing Director and Head of Investment Banking